Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers

@article{Zacny2002CharacterizingTS,
  title={Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers},
  author={James P. Zacny},
  journal={Psychopharmacology},
  year={2002},
  volume={165},
  pages={146-156}
}
  • J. Zacny
  • Published 2002
  • Psychology, Medicine, Biology
  • Psychopharmacology
Abstract Rationale. The subjective, psychomotor, and physiological effects of prescription compounds containing the opioid hydrocodone have not been studied in a population of non-drug-abusing people who might be prescribed these compounds for cough or pain relief. Objectives. To characterize the effects of a hydrocodone combination product, Hycodan, which contains hydrocodone and a peripherally-acting anticholinergic, homatropine, in non-drug-abusing volunteers. Methods. Eighteen volunteers… 

Figures and Tables from this paper

Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers
TLDR
Although oxycodone produced abuse liability-related subjective effects, it also produced unpleasant effects, a phenomenon the authors have observed in other opioid studies in non-drug-abusing volunteers.
Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
TLDR
Differences in magnitude of subjective effects between 10 mg oxycodone/650 mg acetaminophen and placebo are documented, and physicians and pharmacists, and ultimately patients, should be aware of these differences.
Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
TLDR
The oral abuse potential of hydrocodone ER (intact and finely crushed) was significantly lower than hydrocdone IR in healthy, nondependent, recreational opioid users and was generally well tolerated.
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies
TLDR
There were modest potency differences between oxycodone, hydrocodone, and morphine, but their overall profile of effects was similar, indicating significant abuse potential when administered intravenously.
Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: A randomized cross-over trial
The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.
TLDR
The aim was to determine the opioid rotation ratio (ORR) of hydrocodone to morphine equivalent daily dose (MEDD) in cancer outpatients and found 53% had a successful OR with significant improvement in the ESAS pain and symptom distress scores.
...
1
2
3
...

References

SHOWING 1-10 OF 45 REFERENCES
Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers
TLDR
The results of this study demonstrate that 0.33–1.3 mg hydromorphone had orderly, dose-related effects on subjective, psychomotor, and physiological variables, and similar effects to those of a benchmark mu opioid agonist, morphine.
Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
TLDR
The results indicate that 10 mg of nalbuphine produces a profile of subjective, psychomotor and physiological effects similar to that of an equianalgesic dose of morphine (10 mg), which is consistent with both infrahuman studies and studies with nondependent opioid abusers.
Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers.
  • D. Walker, J. Zacny
  • Medicine, Psychology
    The Journal of pharmacology and experimental therapeutics
  • 1999
TLDR
None of the opioids produced consistent effects that are typically associated with abuse liability, suggested that the cumulative-dosing procedure is an efficient way of determining dose-response functions for multiple opioids within the same subjects within thesame study.
Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers.
TLDR
A clinically relevant dose of buprenorphine, 0.3 mg, produced a greater magnitude of subjective and psychomotor-impairing effects than did an equianalgesic dose of morphine.
Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers
TLDR
Orderly dose-response functions and replication of results of single-doses studies confirmed that the cumulative-dosing procedure is an efficient way of determining dose- response functions for multiple opioids within the same subjects.
Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers.
TLDR
The notion that the pharmacodynamic effects of remifentanil are extremely short-lived after the drug is no longer administered must be questioned given the findings that psychomotor effects were still apparent 1 h after the infusion was discontinued.
Methodological considerations in the evaluation of analgesic combinations: acetaminophen (paracetamol) and hydrocodone in postpartum pain.
TLDR
Both the acetaminophen and hydrocodone effects were statistically significant, whereas the interaction contrast was not, which indicates that the analgesic effect of the combination represents the additive effect of its constituents and is consistent with the assumption that these constituents are producing analgesia by different mechanisms.
Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.
...
1
2
3
4
5
...